|
By
Josh Gee
|
|
Monday, 05 January 2015 14:43 |
 Cerus Corporation (NASDAQ:CERS) shares jumped 4% after the company announced that the haemoglobin content (53.1g) of INTERCEPT content treated red blood cell components (RBCs) on day 35 of storage met the protocol defined criteria for equivalence based on the inferiority margin of 5g as compare to conventional red blood cell components (55.8g).
|
|
Read more...
|
|
By
Marilyn Mullen
|
|
Wednesday, 24 December 2014 10:49 |
 PTC Therapeutics, Inc.(NASDAQ:PTCT) had announced that it has commenced a rolling submission of a New Drug Application to the United States Food and Drug Administration (FDA) for the treatment of nonsense mutation Duchenne muscular dystrophy.
|
|
Read more...
|
|
By
Josh Gee
|
|
Monday, 22 December 2014 20:04 |
 After the biotech reported that the NS5A drug of Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) combined with Gilead's Sovaldi scored a quick cure among a small group of hepatitis C patients after only 6 weeks of treatment, the shares of Achillion rose high.
|
|
Read more...
|
|
By
Marilyn Mullen
|
|
Friday, 19 December 2014 14:05 |
 After the announcement of positive results from the pivotal late-stage field study of its novel drug, AT-001 by Aratana Therapeutics Inc. (NASDAQ:PETX), its stock rose over 26% to $16.50.
|
|
Read more...
|
|
By
Josh Gee
|
|
Thursday, 18 December 2014 20:28 |
 Shares of Auspex Pharmaceuticals Inc (NASDAQ:ASPX) were doubled on Wednesday and made a new high after the company reported solid results from phase III study.
|
|
Read more...
|
|
By
Marilyn Mullen
|
|
Monday, 15 December 2014 13:42 |
|
Shares of Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH) have gained almost 40% in the past one month and had reached an all time high of $32.93 On December 10, 2014. The stock has been outperforming the broader market on the buyout buzz.
|
|
Read more...
|
|
By
Josh Gee
|
|
Thursday, 20 November 2014 00:54 |
|
Shares of Agios Pharmaceuticals Inc. (NASDAQ:AGIO) posted its biggest single day rally on Wednesday since 26th September. The stock is up a whopping 15% to $96.25 after hitting an all time high of $96.88 earlier in the session. More than 2.64 million shares have been traded, compared to its 30-day average volume of 707K shares.
|
|
Read more...
|
|
By
Josh Gee
|
|
Tuesday, 18 November 2014 02:58 |
 Shares of TapImmune, Inc. (OTCBB:TPIV) rose nearly 30% on Monday after the firm was mentioned positively by analysts reacting to recently published comments by Chairman & CEO Glynn Wilson, PH.D.
|
|
Read more...
|
|
By
Josh Gee
|
|
Friday, 07 November 2014 15:22 |
 With the main benchmarks hovering near record levels in the wake of a solid jobs report, a key payrolls data showed the economy added 214,000 jobs in October, while the unemployment rate ticked down to 5.8% — a broadly positive reading.
|
|
Read more...
|
|
By
Josh Gee
|
|
Wednesday, 05 November 2014 20:36 |
|
After the Republican Party took control of the Senate in the midterm elections, as expected, and following a stronger-than-anticipated report on the labor market, some weak earnings in the tech sector capped gains in the Nasdaq, but the beaten-down energy sector rallied on hopes a Republican majority could lead to new legislation that impacts the group.
|
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
|
Page 10 of 12 |
